PIRAMAL PHARMA
Back to All Ratios
|
PIRAMAL PHARMA Last 5 Year EBIT Growth History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
EBIT Growth(%) | -67.21 | -38.59 | - |
What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?
Year | EBIT Growth |
---|---|
Mar2023 | -67.21 |
Mar2022 | -38.59 |
Mar2021 | - |
How is EBIT Growth of PIRAMAL PHARMA Trending?
Years | EBIT Growth | % Change | |
---|---|---|---|
Mar2023 | -67.21 | Negative | |
Mar2022 | -38.59 | 0 | |
Mar2021 | 0 | - |
Other Financial Ratios of PIRAMAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹19,836.9 Cr | 2% | 5.4% | 107.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹351,467.0 Cr | -4.9% | -2.6% | 54% | Stock Analytics | |
CIPLA | ₹119,470.0 Cr | -0.1% | 5% | 57.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹116,563.0 Cr | 8.1% | 9.1% | 25.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,690.0 Cr | -2.4% | 10.8% | 110% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,351.1 Cr | 1.4% | -4.8% | 30.2% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 2% |
5.4% |
107.1% |
SENSEX | 1.7% |
1.1% |
21.3% |
You may also like the below Video Courses